Wire Stories

Samsung Bioepis Announces FDA Approval of 420 mg Multi-dose Vial of ONTRUZANT® (trastuzumab-dttb)

●150 mg and 420 mg vial of ONTRUZANT® are now approved INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis…

IASO Biotherapeutics Raises $60 Million in Series B Financing Led by GL Ventures to Advance Cell Therapies for Cancer Care

NANJING, China--(BUSINESS WIRE)--IASO Biotherapeutics (IASO BIO) today announced the completion of $60 million in series…

Razer Announces 2019 Full Year Financial Results

 Revenues Reached Record High Of US$820.8M Adjusted Ebitda Breakeven in Second Half of 2019 (Excluding…

Europe & Asia Pacific Kraft Papers Market Outlook & Projections from 2019 to 2027 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)-- The "Europe & Asia Pacific Kraft Papers Market Outlook and Projections, 2019-2027" report…

A Remarkable Place Produces Outstanding People: The Influence of Guang’an on Deng Xiaoping

GUANG’AN, China--(BUSINESS WIRE)--Guang’an, a peaceful and beautiful city in the east of China’s Sichuan Province,…

A Remarkable Place Produces Outstanding People: The Influence of Guang’an on Deng Xiaoping

GUANG’AN, China--(BUSINESS WIRE)--Guang’an, a peaceful and beautiful city in the east of China’s Sichuan Province,…

AJC Proposes Key to Empower ASEAN Agribusiness: How to Participate More in Agribusiness Global Value Chains

TOKYO--(BUSINESS WIRE)--Does competitiveness of agribusiness really increase in ASEAN? The answer is yes according to…

Elliptic Labs Launches a New Design Win for Xiaomi Redmi K30 Pro Smartphone

OSLO, Norway--(BUSINESS WIRE)--In the race to roll out modern, feature-rich smartphones, China's giant Xiaomi has…

Masimo and University Hospitals Jointly Announce Masimo SafetyNet™, a New Remote Patient Management Solution Designed to Aid COVID-19 Response Efforts

Telehealth System Combines Radius PPG™ Tetherless Pulse Oximetry and the Doctella™ Platform IRVINE, Calif. &…

EpimAb Biotherapeutics Appoints David Gu, Ph.D. as New Chief Financial Officer to Drive Corporate Development Plans

SHANGHAI--(BUSINESS WIRE)--EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, today announced the…